MedTrace Logo

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

NCT06687408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-04-24

No results posted yet for this study

Summary

The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is:

Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?

Conditions

  • Lung Cancer, Non-Small Cell

Interventions

PROCEDURE

RATS Group

The participants with centrally located lung cancer in this group were performed sleeve lobectomy in robotic-assisted thoracic surgery (RATS) approach, which has been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently.

PROCEDURE

VATS group

The participants with centrally located lung cancer in this group were performed sleeve lobectomy in video-assisted thoracic surgery (VATS) approach.

Sponsors & Collaborators

  • Shanghai Chest Hospital of Shanghai Jiao Tong University

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Haifeng Shen, M.D. · Second Affiliated Hospital, School of Medicine, Zhejiang University

  • Xinghua Cheng, M.D. Ph.D. · Shanghai Chest Hospital of Shanghai Jiao Tong University

  • Yuhan Zhou, M.D. · Sir Run Run Shaw Hospital

  • Junqiang Fan, M.D. · Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06687408 on ClinicalTrials.gov